The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus.
Mátyás, Csaba
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus. [electronic resource] - Cardiovascular diabetology Oct 2015 - 145 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1475-2840
10.1186/s12933-015-0309-x doi
Animals
Benzoates--pharmacology
Cyclic GMP--metabolism
DNA Damage--drug effects
Diabetes Mellitus, Experimental--metabolism
Diabetes Mellitus, Type 1--metabolism
Diabetic Cardiomyopathies
Disease Models, Animal
Fibrosis
Heart--drug effects
Immunohistochemistry
In Situ Nick-End Labeling
Myocardium--pathology
Nitric Oxide--metabolism
Rats
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus. [electronic resource] - Cardiovascular diabetology Oct 2015 - 145 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1475-2840
10.1186/s12933-015-0309-x doi
Animals
Benzoates--pharmacology
Cyclic GMP--metabolism
DNA Damage--drug effects
Diabetes Mellitus, Experimental--metabolism
Diabetes Mellitus, Type 1--metabolism
Diabetic Cardiomyopathies
Disease Models, Animal
Fibrosis
Heart--drug effects
Immunohistochemistry
In Situ Nick-End Labeling
Myocardium--pathology
Nitric Oxide--metabolism
Rats